Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

BACKGROUND: Cerebral amyloid angiopathy (CAA) is a disease caused by the accumulation of the amyloid-beta protein and is a major cause of intracerebral hemorrhage (ICH) and vascular dementia in the elderly. The presence of the amyloid-beta protein in the vessel wall may induce a chronic state of cer...

Descripción completa

Detalles Bibliográficos
Autores principales: Voigt, S., Koemans, E. A., Rasing, I., van Etten, E. S., Terwindt, G. M., Baas, F., Kaushik, K., van Es, A. C. G. M., van Buchem, M. A., van Osch, M. J. P., van Walderveen, M. A. A., Klijn, C. J. M., Verbeek, M. M., van der Weerd, L., Wermer, M. J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241553/
https://www.ncbi.nlm.nih.gov/pubmed/37277877
http://dx.doi.org/10.1186/s13063-023-07371-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241553/
https://www.ncbi.nlm.nih.gov/pubmed/37277877
http://dx.doi.org/10.1186/s13063-023-07371-4

Ejemplares similares